Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $31.50 | 1 | 53.8% |
| Food and Beverage | $27.03 | 2 | 46.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orexigen Therapeutics, Inc. | $31.50 | 1 | $0 (2017) |
| Biogen, Inc. | $16.23 | 1 | $0 (2021) |
| SANOFI PASTEUR INC. | $10.80 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $16.23 | 1 | Biogen, Inc. ($16.23) |
| 2019 | $10.80 | 1 | SANOFI PASTEUR INC. ($10.80) |
| 2017 | $31.50 | 1 | Orexigen Therapeutics, Inc. ($31.50) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROLOGY | ||||||
| 08/12/2019 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT (Drug), ADACEL, MENACTRA | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: VACCINES | ||||||
| 08/01/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: OBESITY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 907 | 5,067 | $358,303 | $147,998 |
| 2022 | 18 | 963 | 1,366 | $230,625 | $89,375 |
| 2021 | 8 | 459 | 529 | $78,594 | $36,686 |
| 2020 | 18 | 1,064 | 1,445 | $213,330 | $92,713 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 2,340 | $84,420 | $43,388 | 51.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 376 | $94,000 | $29,562 | 31.4% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 11 | 1,200 | $52,800 | $20,885 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 124 | 124 | $27,896 | $15,242 | 54.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 64 | $21,760 | $7,897 | 36.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $10,934 | $6,224 | 56.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 37 | 109 | $16,350 | $4,971 | 30.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 29 | 31 | $11,256 | $4,795 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 61 | $10,980 | $3,461 | 31.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 48 | 48 | $5,904 | $3,453 | 58.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 71 | $4,016 | $2,033 | 50.6% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 15 | 76 | $3,800 | $1,478 | 38.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 147 | $6,468 | $1,475 | 22.8% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 17 | 17 | $1,831 | $1,162 | 63.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $1,626 | $916.16 | 56.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 16 | 71 | $1,349 | $540.31 | 40.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 35 | $840.00 | $333.20 | 39.7% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 43 | 172 | $1,204 | $86.92 | 7.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 23 | $437.00 | $50.60 | 11.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 48 | $432.00 | $45.13 | 10.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 247 | 445 | $111,250 | $34,270 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 160 | 160 | $32,320 | $19,964 | 61.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 67 | $22,780 | $7,652 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 91 | $16,380 | $5,567 | 34.0% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 65 | 68 | $3,944 | $3,872 | 98.2% |
About Eric Poplin
Eric Poplin is a Occupational Medicine healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275503815.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Poplin has received a total of $58.53 in payments from pharmaceutical and medical device companies, with $16.23 received in 2021. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Education" ($31.50).
As a Medicare-enrolled provider, Poplin has provided services to 3,393 Medicare beneficiaries, totaling 8,407 services with total Medicare billing of $366,771. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Occupational Medicine
- Other Specialties Family Medicine
- Location Greenwood, IN
- Active Since 01/25/2006
- Last Updated 07/01/2024
- Taxonomy Code 2083X0100X
- Entity Type Individual
- NPI Number 1275503815
Products in Payments
- CONTRAVE (Drug) $31.50
- ADUHELM (Biological) $16.23
- FLUBLOK QUADRIVALENT (Drug) $10.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.